Lexicon Pharmaceuticals, Inc.
LXRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $21 | $63 | $67 |
| Short-Term Investments | $66 | $118 | $132 | $171 |
| Receivables | $2 | $2 | $47 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $3 | $5 |
| Total Curr. Assets | $123 | $145 | $246 | $246 |
| Property Plant & Equip (Net) | $9 | $7 | $7 | $7 |
| Goodwill | $45 | $45 | $45 | $45 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $29 | $29 | $0 | $0 |
| Total NC Assets | $83 | $80 | $52 | $52 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $206 | $226 | $298 | $298 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $11 | $15 |
| Short-Term Debt | $2 | $1 | $43 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4 | $17 | $45 | $0 |
| Other Curr. Liab. | $12 | $11 | $12 | $29 |
| Total Curr. Liab. | $22 | $35 | $111 | $45 |
| LT Debt | $57 | $56 | $59 | $107 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $8 | $5 | $5 | $0 |
| Total NC Liab. | $64 | $61 | $64 | $107 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $1 | $8 |
| Total Liabilities | $86 | $96 | $175 | $152 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,002 | -$1,989 | -$1,993 | -$1,967 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $2,122 | $2,118 | $2,115 | $2,113 |
| Total Equity | $120 | $129 | $123 | $146 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $206 | $226 | $298 | $298 |
| Net Debt | $8 | $36 | $39 | $42 |